New eye disease detection equipment receives FDA approval

RetinaPharma Technologies has received FDA approval for its product TonoPach which allows greater accuracy in the diagnosis of glaucoma and ocular hypertension. These two conditions are the leading cause of irreversible adult blindness and impaired vision. There are 7.5 million sufferers in the US of which more than 130,000 are legally blind. The product simultaneously measures corneal thickness and intraocular pressure. Having the two measures done together increases the accuracy. For example, laser vision corrective surgery and some diseases can cause thinning of the cornea which can interfere with the intraocular pressure reading and therefore cause glaucoma to be missed. Traditionally, only intraocular pressure readings were used to diagnose glaucoma or ocular hypertension but it has since been found that corneal thickness needs to be added to the equation to derive and accurate result.

Source: summary of medical news story as reported by Mysan - PR Newswire

Related Disease Topics:

• Glaucoma
• Ocular hypertension
• Blindness
• Impaired vision

Related Symptom Topics:

• High intraocular pressure

Article Source Details

About: New eye disease detection equipment receives FDA approval

Date: 6 January 2005

Source: Mysan - PR Newswire

URL: http://www.mysan.de/international/article20795.html

Related Medical Topics

This summary article refers to the following medical categories:

• Diagnosis
• Diagnosis and glaucoma
• Diagnosis and ocular hypertension
• Diagnosis and blindness
• Diagnosis and impaired vision
• Diagnosis and high intraocular pressure
• Statistics
• Surgery
• Surgery and glaucoma
• Surgery and ocular hypertension
• Undiagnosed
• Undiagnosed and intraocular hypertension
• Undiagnosed and glaucoma

More News Topics

Search Specialists by State and City